Hsu, S., Pimenova, A.A., Hayes, K., (…), Goate, A.M., *Karch, C.M. Neurobiology of DiseaseVolume 139, June 2020, Article number 104817.
Dube, U., Del-Aguila, J.L., Li, Z., (…), *Karch, CM., Harari, O., Cruchaga, C. Nature Neuroscience, 22(11), pp. 1903-1912, 2019.
Sirkis, D.W., Bonham, L.W., *Karch, C.M., Yokoyama, J.S. Current Opinion in Neurology, 32(2), pp. 272-278, 2019.
Jiang, S., Wen, N., Li, Z., (…), Cruchaga, C., Karch, C.M. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP. Transl Psych 8, art. no. 265, 2018.
Tavana, J.P., Rosene, M., Jensen, N.O., (…), Kauwe, J.S.K., Karch, C.M. RAB10: An alzheimer’s disease resilience locus and potential drug target. Clin Interventions Aging, 14:73-9, 2019.
Celeste Karch PhD (Psychiatry) was awarded a collaborative grant from the Chan Zuckerberg Initiative to study the role of TREM2 in Alzheimer’s Disease. This collaborative grant is part of the larger Neurodegeneration Challenge Network, and also features WUSTL faculty members Carlos Cruchaga, Gregory Day, and Oscar Harari.